Sponsored

Rritual Superfoods’ (RSF:CSE) Chief Innovation Officer Rolls Out R&D Division

Summary

  • Rritual Superfoods has just got a new Research and Development (R&D) division.
  • The R&D division has been launched by the Company’s Chief Innovation Officer, Stacey Gillespie.
  • The Company also highlighted that Ms Gillespie had endorsed its functional superfoods product pipeline for the national launch.
  • Rritual has established the leadership and expertise for generating long-term organisational skill and knowledge.

Rritual Superfoods Inc (RSF:CSE) announced that its Chief Innovation Officer Stacey Gillespie had introduced a Research and Development (R&D) division, which will help in establishing best practices for the development of a significant product pipeline.

Besides stepping up the Company’s R&D functions, Stacey Gillespie has also endorsed its functional superfoods product pipeline for the national launch.

To define the functional superfoods region, Rritual has established the leadership and expertise for generating long-term organisational skill and knowledge in its product development approach to cater to the end consumer.

DO READ: Rritual (RSF:CSE) ropes in Sarton Molnar-Fenton to turbocharge sales strategy

Currently, Rritual adopts a method for product development that combines best practices with agility for the identification of categories having superior growth potential, including its leading mushrooms and adaptogens product line, and new line of innovative products.

On the advancement of R&D Practices by Stacey Gillespie, David Kerbel, CEO of Rritual, commented-

Adding to this, Stacey Gillespie stated-

ALSO READ: Rritual Superfoods (RSF:CSE) scales up 3rd manufacturing run to meet rising retail demand

Rritual’s new line of Innovative products

Rritual’s innovative product pipeline will take advantage of the developing and recently announced distribution agreements that will carry the complete flagship product line of Rritual. Consequently, these innovative products would be exposed to key wellness retailers as well as sales platforms, such as CrossMark.

GOOD READ: Rritual Superfoods (RSF:CSE) teams up with CROSSMARK Inc. to rev up its brand growth

Rritual’s Product Pipeline for Q2/Q3 is illustrated below:

Rritual believes that functional foods as well as superfoods provide maximum nutritional benefits. They also contain antioxidants, vitamins, as well as minerals. Besides, they can possess distinctive properties for boosting immunity, improving brain function, and others.

The newly appointed Chief Innovation Officer said, "As an emerging category, consumer interest for Superfoods is building rapidly, and Rritual in embracing a consumer centric model is cognizant of the opportunity that exists to educate consumers in addition to providing them with a line of products that are differentiated, efficacious and most importantly taste good."

What adds to their appeal is that Rrituals’s product offerings are all certified as organic from the USDA (United States Department of Agriculture) and have no caffeine. The products can be mixed with other beverages or served by themselves.

It is noteworthy to mention that the exclusive Immune-Synergy Six Mushroom Blend of Rritual Superfoods is the only functional health product available in the market comprising a daily prebiotic mix. This prebiotic blend promotes the formation of a healthy gut microbiome and provides balanced digestive function.

On 5 May 2021, RSF shares closed the market at CA$0.75.


Disclaimer
The website https://kalkinemedia.com/ca is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001. The principal purpose of the content on the website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.
   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK